150 likes | 279 Views
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action. Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch. 2012 CSTE Annual Conference HIV Surveillance Pre-conference Workshop Omaha, NE June 3, 2012.
E N D
Monitoring Indicators of the National HIV/AIDS StrategyUsing Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch 2012 CSTE Annual Conference HIV Surveillance Pre-conference Workshop Omaha, NE June 3, 2012 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention
National HIV/AIDS Strategy (NHAS)Indicator Program • CDC developed a SAS program to assist local and state HIV surveillance programs to assess: • Linkage to care within 3, 6, and 12 months following HIV infection diagnosis, and • Retention in care and viral load suppression among persons living with diagnosed HIV infection • The fully automated SAS program was made available on HICSB’s SiteScape (now SharePoint) on January 12, 2012
NHAS Indicator Program - Definitions • Linkage to care: • There is at least one result of a CD4 or viral load test based on a specimen collected within the specified time period following diagnosis • Retention in HIV care • Had at least two CD4 and/or viral load tests (two care visits) at least three months apart during the specified year • Viral suppression • The most recent viral load measured during the specified year was less than or equal (≤) 200 copies per milliliter
NHAS Indicator Program – Reporting Delays • Recommendation: • Linkage to care: allow at least 3 months delay for reporting and data entry of laboratory test results (after observation period) • Retention in care and viral suppression: allow at least 18 months delay in death reporting • Table footnotes will indicate if insufficient length of time has been given to account for reporting delays
NHAS Indicator Program – Case Inclusion Criteria • Meet the surveillance case definition of HIV infection • Resided in the area when diagnosed with HIV • Person View status is ‘A – Active’, ‘R – Required field missing’, or ‘W – Warning’ • Linkage to care: • Year and month of HIV diagnosis are known • At least 13 years old at the time of diagnosis • Irrespective of vital status after diagnosis • Retention in care and viral suppression: • Year of HIV diagnosis is known • At least 13 years old at the end of the specified time period • Presumed alive at the end of the specified time period
NHAS Indicator Program – Test Inclusion Criteria • CD4 (count or percent) • HIV viral load • Linkage to care: specimen collected in or after the month of HIV diagnosis • Viral suppression: result or result interpretation is not blank
National HIV/AIDS Strategy (NHAS)Line-listing Program • CDC is developing a SAS program to assist local and state HIV surveillance programs to list persons: • Not linked to care within 3, 6, and 12 months following HIV infection diagnosis (no CD4 or VL test within time period) • Not in care during specified time period (no CD4 or VL test in time period) • The SAS program is currently being revised after preliminary testing • Output to list facility of latest document
Line-listing Program • Specifications • Case inclusion criteria: see NHAS program • HIV infected people who are alive at the time of the data run • 2 sets of outputs: (1) no cd4/VL and (2) no lab within the time period • Reporting delays: see NHAS program • Note: laws/regulations, completeness of lab reporting, and data entry will affect results
Line Listing Variables • Care: No CD4/VL, No lab • Diagnosis: date, status, PV status • ID: STATENO, eHARS unique identifier, Document ID • Personal identifiers: name, address at dx, current • RIDR duplicate status • Vital status
Line-listing Program: Output—Not in Care Facility information from most recent lab report available; or, if no lab report available, facility of diagnosis.
AcknowledgementsTian TangAruna Surendera BabuMi ChenState and local surveillance program staff The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention